Alpha Teknova, Inc. (TKNO) 10-Year Financial Performance & Capital Metrics

TKNO • • Industrial / General

HealthcareSpecialty & Generic PharmaContract Manufacturing & APIAPI Manufacturers

AboutAlpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It serves life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and government research institutions. The company was founded in 1996 and is headquartered in Hollister, California.Show more

Revenue $38M +2.9%
EBITDA -$20M +34.6%
Net Income -$27M +27.3%
EPS (Diluted) -0.57 +50.9%
Gross Margin 19.16% -31.7%
EBITDA Margin -51.84% +36.4%
Operating Margin -69.27% +28.5%
Net Margin -70.86% +29.3%
ROE -31.02% +19.9%
ROIC -19.52% +29.7%
Debt/Equity 0.37 +8.2%
Interest Coverage -38.06 +10.9%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Strong 5Y sales CAGR of 13.4%

✗Weaknesses

✗Weak Piotroski F-Score: 3/9
✗Negative free cash flow
✗Weak momentum: RS Rating 18 (bottom 18%)
✗Low quality earnings: Net income not backed by cash flow
✗Shares diluted 46.9% in last year
✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y13.44%

3Y0.76%

TTM9.5%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM42.49%

EPS CAGR

10Y-

5Y-

3Y-

TTM54.78%

ROCE

10Y Avg-14.92%

5Y Avg-17.21%

3Y Avg-27.78%

Latest-23.01%

Peer Comparison

API Manufacturers

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
TKNOAlpha Teknova, Inc.	198.06M	3.70	-6.49	2.89%	-45.78%	-25.08%		0.37
BGMBGM Group Ltd.	635.79M	3.52	-17.60	-45.99%	-5.75%	-3.26%

Profit & Loss

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	20.09M	31.3M	36.89M	41.42M	36.68M	37.74M
Revenue Growth %	-	0.56%	0.18%	0.12%	-0.11%	0.03%
Cost of Goods Sold+	11.52M	13.54M	19.27M	23.94M	26.39M	30.51M
COGS % of Revenue	0.57%	0.43%	0.52%	0.58%	0.72%	0.81%
Gross Profit+	8.57M	17.75M	17.62M	17.48M	10.3M	7.23M
Gross Margin %	0.43%	0.57%	0.48%	0.42%	0.28%	0.19%
Gross Profit Growth %	-	1.07%	-0.01%	-0.01%	-0.41%	-0.3%
Operating Expenses+	10.43M	13.09M	29.63M	67.14M	45.86M	33.38M
OpEx % of Revenue	0.52%	0.42%	0.8%	1.62%	1.25%	0.88%
Selling, General & Admin	8.56M	10.44M	24.17M	37.45M	34.78M	29.47M
SG&A % of Revenue	0.43%	0.33%	0.66%	0.9%	0.95%	0.78%
Research & Development	769K	1.51M	4.31M	7.74M	5.57M	2.76M
R&D % of Revenue	0.04%	0.05%	0.12%	0.19%	0.15%	0.07%
Other Operating Expenses	1.1M	1.15M	1.15M	21.95M	5.51M	1.15M
Operating Income+	-1.86M	4.66M	-12.01M	-49.66M	-35.56M	-26.15M
Operating Margin %	-0.09%	0.15%	-0.33%	-1.2%	-0.97%	-0.69%
Operating Income Growth %	-	3.51%	-3.58%	-3.14%	0.28%	0.26%
EBITDA+	-233K	6.71M	-9.13M	-46.49M	-29.9M	-19.57M
EBITDA Margin %	-0.01%	0.21%	-0.25%	-1.12%	-0.82%	-0.52%
EBITDA Growth %	-	29.79%	-2.36%	-4.1%	0.36%	0.35%
D&A (Non-Cash Add-back)	1.62M	2.04M	2.88M	3.17M	5.66M	6.58M
EBIT	-1.86M	4.66M	-12.01M	-28.86M	-31.2M	-26.15M
Net Interest Income+	66K	87K	-589K	213K	-833K	-687K
Interest Income	66K	87K	0	213K	0	0
Interest Expense	0	0	589K	0	833K	687K
Other Income/Expense	56K	63K	-629K	268K	-1.51M	-687K
Pretax Income+	-1.8M	4.73M	-12.64M	-49.39M	-37.08M	-26.83M
Pretax Margin %	-0.09%	0.15%	-0.34%	-1.19%	-1.01%	-0.71%
Income Tax+	-495K	1.16M	-2.83M	-1.92M	-298K	-88K
Effective Tax Rate %	0.72%	0.76%	0.78%	0.96%	0.99%	1%
Net Income+	-1.3M	3.57M	-9.8M	-47.47M	-36.78M	-26.75M
Net Margin %	-0.06%	0.11%	-0.27%	-1.15%	-1%	-0.71%
Net Income Growth %	-	3.74%	-3.75%	-3.84%	0.23%	0.27%
Net Income (Continuing)	-1.3M	3.57M	-9.8M	-47.47M	-36.78M	-26.75M
Discontinued Operations	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0
EPS (Diluted)+	-0.36	0.16	-0.35	-1.69	-1.16	-0.57
EPS Growth %	-	1.44%	-3.19%	-3.83%	0.31%	0.51%
EPS (Basic)	-0.05	0.03	-0.35	-1.69	-1.16	-0.57
Diluted Shares Outstanding	3.64M	3.98M	28.01M	28.08M	31.82M	46.75M
Basic Shares Outstanding	26.11M	21.11M	28.01M	28.08M	31.82M	46.75M
Dividend Payout Ratio	-	-	-	-	-	-

Balance Sheet

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	15.42M	16.41M	101.2M	61.14M	45.66M	42.78M
Cash & Short-Term Investments	9.68M	5.13M	87.52M	42.24M	28.48M	30.4M
Cash Only	4.14M	3.31M	87.52M	42.24M	28.48M	3.71M
Short-Term Investments	5.53M	1.81M	0	0	0	26.69M
Accounts Receivable	2.99M	6.57M	5.85M	4.28M	3.95M	4.31M
Days Sales Outstanding	54.24	76.61	57.92	37.74	39.28	41.7
Inventory	2.57M	3.58M	5.39M	12.25M	11.59M	6.8M
Days Inventory Outstanding	81.3	96.55	102.16	186.69	160.37	81.35
Other Current Assets	0	1.14M	0	0	1.63M	1.27M
Total Non-Current Assets+	43.09M	46.5M	65.31M	91.12M	82.93M	75.99M
Property, Plant & Equipment	5.45M	10.01M	29.81M	71.31M	66.84M	61.52M
Fixed Asset Turnover	3.69x	3.13x	1.24x	0.58x	0.55x	0.61x
Goodwill	16.61M	16.61M	16.61M	0	0	0
Intangible Assets	21M	19.85M	18.7M	17.56M	14.24M	13.09M
Long-Term Investments	0	0	0	0	0	0
Other Non-Current Assets	32K	24K	180K	2.25M	1.85M	1.38M
Total Assets+	58.51M	62.91M	166.51M	152.26M	128.59M	118.77M
Asset Turnover	0.34x	0.50x	0.22x	0.27x	0.29x	0.32x
Asset Growth %	-	0.08%	1.65%	-0.09%	-0.16%	-0.08%
Total Current Liabilities+	5.58M	3.96M	7.74M	10.88M	8.88M	11.21M
Accounts Payable	768K	1.64M	2.25M	2.45M	1.49M	825K
Days Payables Outstanding	24.33	44.07	42.58	37.33	20.65	9.87
Short-Term Debt	45K	0	0	0	0	4.04M
Deferred Revenue (Current)	0	0	200K	198K	16K	30K
Other Current Liabilities	0	845K	0	0	0	0
Current Ratio	2.76x	4.14x	13.07x	5.62x	5.14x	3.82x
Quick Ratio	2.30x	3.24x	12.37x	4.50x	3.84x	3.21x
Cash Conversion Cycle	111.21	129.09	117.5	187.1	179	113.18
Total Non-Current Liabilities+	40.02M	6.54M	15.56M	41.5M	29.68M	25.16M
Long-Term Debt	0	0	11.87M	21.98M	13.25M	9.44M
Capital Lease Obligations	0	0	0	18.11M	15.4M	14.88M
Deferred Tax Liabilities	3.9M	5.99M	3.15M	1.22M	919K	827K
Other Non-Current Liabilities	36.12M	554K	542K	191K	102K	10K
Total Liabilities	45.6M	10.51M	23.31M	52.38M	38.55M	36.38M
Total Debt+	45K	0	11.87M	42.31M	30.46M	30.17M
Net Debt	-4.1M	-3.31M	-75.65M	74K	1.97M	26.46M
Debt / Equity	0.00x	-	0.08x	0.42x	0.34x	0.37x
Debt / EBITDA	-	-	-	-	-	-
Net Debt / EBITDA	-	-0.49x	-	-	-	-
Interest Coverage	-	-	-20.39x	-	-42.69x	-38.06x
Total Equity+	12.91M	52.41M	143.2M	99.89M	90.04M	82.39M
Equity Growth %	-	3.06%	1.73%	-0.3%	-0.1%	-0.08%
Book Value per Share	3.55	13.18	5.11	3.56	2.83	1.76
Total Shareholders' Equity	12.91M	52.41M	143.2M	99.89M	90.04M	82.39M
Common Stock	0	0	0	0	0	1K
Retained Earnings	-1.3M	2.27M	-7.54M	-55.01M	-91.79M	-118.53M
Treasury Stock	0	0	0	0	0	0
Accumulated OCI	20K	7K	0	0	0	0
Minority Interest	0	0	0	0	0	0

Cash Flow

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	2.17M	2.5M	-9.07M	-27.4M	-18.81M	-12.39M
Operating CF Margin %	0.11%	0.08%	-0.25%	-0.66%	-0.51%	-0.33%
Operating CF Growth %	-	0.15%	-4.62%	-2.02%	0.31%	0.34%
Net Income	-1.3M	3.57M	-9.8M	-47.47M	-36.78M	-26.75M
Depreciation & Amortization	1.62M	2.04M	2.88M	3.17M	5.66M	6.58M
Stock-Based Compensation	0	300K	1.55M	3.71M	4.14M	3.67M
Deferred Taxes	-457K	2.09M	-2.84M	-1.93M	-304K	-92K
Other Non-Cash Items	12K	7K	906K	22.46M	6.22M	5.08M
Working Capital Changes	2.3M	-5.51M	-1.77M	-7.33M	2.25M	-873K
Change in Receivables	-104K	-2.35M	-49K	380K	314K	-494K
Change in Inventory	996K	-987K	-2.25M	-7.55M	330K	244K
Change in Payables	1.19M	-89K	270K	572K	-773K	-594K
Cash from Investing+	-8.16M	-1.74M	-17.52M	-28.15M	-7.74M	-27.27M
Capital Expenditures	-2.65M	-5.47M	-19.88M	-28.15M	-7.93M	-1.13M
CapEx % of Revenue	0.13%	0.17%	0.54%	0.68%	0.22%	0.03%
Acquisitions	-	-	-	-	-	-
Investments	-	-	-	-	-	-
Other Investing	61K	27K	529K	0	197K	125K
Cash from Financing+	8.57M	-1.6M	110.79M	10.27M	12.8M	14.89M
Debt Issued (Net)	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-
Other Financing	-6.75M	-1.55M	-3.77M	-307K	-32K	-214K
Net Change in Cash	-	-	-	-	-	-
Free Cash Flow+	-477K	-2.96M	-28.95M	-55.55M	-26.75M	-13.52M
FCF Margin %	-0.02%	-0.09%	-0.78%	-1.34%	-0.73%	-0.36%
FCF Growth %	-	-5.21%	-8.78%	-0.92%	0.52%	0.49%
FCF per Share	-0.13	-0.74	-1.03	-1.98	-0.84	-0.29
FCF Conversion (FCF/Net Income)	-1.66x	0.70x	0.93x	0.58x	0.51x	0.46x
Interest Paid	59K	36K	414K	0	0	1.55M
Taxes Paid	95K	323K	8K	0	0	39K

Key Ratios

Metric	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-10.11%	10.93%	-10.02%	-39.05%	-38.73%	-31.02%
Return on Invested Capital (ROIC)	-15.8%	12.08%	-15.44%	-44.47%	-27.79%	-19.52%
Gross Margin	42.67%	56.73%	47.76%	42.19%	28.07%	19.16%
Net Margin	-6.49%	11.41%	-26.57%	-114.6%	-100.26%	-70.86%
Debt / Equity	0.00x	-	0.08x	0.42x	0.34x	0.37x
Interest Coverage	-	-	-20.39x	-	-42.69x	-38.06x
FCF Conversion	-1.66x	0.70x	0.93x	0.58x	0.51x	0.46x
Revenue Growth	-	55.75%	17.88%	12.27%	-11.43%	2.89%

Revenue by Segment

	2021	2022	2023	2024
Lab Essentials	27.18M	31.77M	28.8M	28.88M
Lab Essentials Growth	-	16.88%	-9.35%	0.29%
Clinical Solutions	6.79M	8.45M	6.74M	7.1M
Clinical Solutions Growth	-	24.32%	-20.21%	5.33%
Other Product	1.39M	1.2M	1.15M	1.76M
Other Product Growth	-	-13.64%	-4.26%	54.01%
Sample Transport	1.53M	6K	-	-
Sample Transport Growth	-	-99.61%	-	-

Revenue by Geography

	2021	2022	2023	2024
UNITED STATES	-	40.1M	35M	35.92M
UNITED STATES Growth	-	-	-12.72%	2.63%
Non-US	-	1.32M	1.68M	1.83M
Non-US Growth	-	-	27.87%	8.43%
U S	35.81M	-	-	-
U S Growth	-	-	-	-
Non Us	1.08M	-	-	-
Non Us Growth	-	-	-	-

Frequently Asked Questions

Growth & Financials

Alpha Teknova, Inc. (TKNO) reported $39.8M in revenue for fiscal year 2024. This represents a 98% increase from $20.1M in 2019.

Alpha Teknova, Inc. (TKNO) grew revenue by 2.9% over the past year. Growth has been modest.

Alpha Teknova, Inc. (TKNO) reported a net loss of $18.2M for fiscal year 2024.

Dividend & Returns

Alpha Teknova, Inc. (TKNO) has a return on equity (ROE) of -31.0%. Negative ROE indicates the company is unprofitable.

Alpha Teknova, Inc. (TKNO) had negative free cash flow of $10.4M in fiscal year 2024, likely due to heavy capital investments.

← Back to Screener

US Stock Screener

...

Alpha Teknova, Inc. (TKNO) 10-Year Financial Performance & Capital Metrics

TKNO • • Industrial / General

HealthcareSpecialty & Generic PharmaContract Manufacturing & APIAPI Manufacturers

Revenue $38M +2.9%
EBITDA -$20M +34.6%
Net Income -$27M +27.3%
EPS (Diluted) -0.57 +50.9%
Gross Margin 19.16% -31.7%
EBITDA Margin -51.84% +36.4%
Operating Margin -69.27% +28.5%
Net Margin -70.86% +29.3%
ROE -31.02% +19.9%
ROIC -19.52% +29.7%
Debt/Equity 0.37 +8.2%
Interest Coverage -38.06 +10.9%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Strong 5Y sales CAGR of 13.4%

✗Weaknesses

✗Weak Piotroski F-Score: 3/9
✗Negative free cash flow
✗Weak momentum: RS Rating 18 (bottom 18%)
✗Low quality earnings: Net income not backed by cash flow
✗Shares diluted 46.9% in last year
✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y13.44%

3Y0.76%

TTM9.5%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM42.49%

EPS CAGR

10Y-

5Y-

3Y-

TTM54.78%

ROCE

10Y Avg-14.92%

5Y Avg-17.21%

3Y Avg-27.78%

Latest-23.01%

Peer Comparison

API Manufacturers

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
TKNOAlpha Teknova, Inc.	198.06M	3.70	-6.49	2.89%	-45.78%	-25.08%		0.37
BGMBGM Group Ltd.	635.79M	3.52	-17.60	-45.99%	-5.75%	-3.26%

Profit & Loss

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	20.09M	31.3M	36.89M	41.42M	36.68M	37.74M
Revenue Growth %	-	0.56%	0.18%	0.12%	-0.11%	0.03%
Cost of Goods Sold+	11.52M	13.54M	19.27M	23.94M	26.39M	30.51M
COGS % of Revenue	0.57%	0.43%	0.52%	0.58%	0.72%	0.81%
Gross Profit+	8.57M	17.75M	17.62M	17.48M	10.3M	7.23M
Gross Margin %	0.43%	0.57%	0.48%	0.42%	0.28%	0.19%
Gross Profit Growth %	-	1.07%	-0.01%	-0.01%	-0.41%	-0.3%
Operating Expenses+	10.43M	13.09M	29.63M	67.14M	45.86M	33.38M
OpEx % of Revenue	0.52%	0.42%	0.8%	1.62%	1.25%	0.88%
Selling, General & Admin	8.56M	10.44M	24.17M	37.45M	34.78M	29.47M
SG&A % of Revenue	0.43%	0.33%	0.66%	0.9%	0.95%	0.78%
Research & Development	769K	1.51M	4.31M	7.74M	5.57M	2.76M
R&D % of Revenue	0.04%	0.05%	0.12%	0.19%	0.15%	0.07%
Other Operating Expenses	1.1M	1.15M	1.15M	21.95M	5.51M	1.15M
Operating Income+	-1.86M	4.66M	-12.01M	-49.66M	-35.56M	-26.15M
Operating Margin %	-0.09%	0.15%	-0.33%	-1.2%	-0.97%	-0.69%
Operating Income Growth %	-	3.51%	-3.58%	-3.14%	0.28%	0.26%
EBITDA+	-233K	6.71M	-9.13M	-46.49M	-29.9M	-19.57M
EBITDA Margin %	-0.01%	0.21%	-0.25%	-1.12%	-0.82%	-0.52%
EBITDA Growth %	-	29.79%	-2.36%	-4.1%	0.36%	0.35%
D&A (Non-Cash Add-back)	1.62M	2.04M	2.88M	3.17M	5.66M	6.58M
EBIT	-1.86M	4.66M	-12.01M	-28.86M	-31.2M	-26.15M
Net Interest Income+	66K	87K	-589K	213K	-833K	-687K
Interest Income	66K	87K	0	213K	0	0
Interest Expense	0	0	589K	0	833K	687K
Other Income/Expense	56K	63K	-629K	268K	-1.51M	-687K
Pretax Income+	-1.8M	4.73M	-12.64M	-49.39M	-37.08M	-26.83M
Pretax Margin %	-0.09%	0.15%	-0.34%	-1.19%	-1.01%	-0.71%
Income Tax+	-495K	1.16M	-2.83M	-1.92M	-298K	-88K
Effective Tax Rate %	0.72%	0.76%	0.78%	0.96%	0.99%	1%
Net Income+	-1.3M	3.57M	-9.8M	-47.47M	-36.78M	-26.75M
Net Margin %	-0.06%	0.11%	-0.27%	-1.15%	-1%	-0.71%
Net Income Growth %	-	3.74%	-3.75%	-3.84%	0.23%	0.27%
Net Income (Continuing)	-1.3M	3.57M	-9.8M	-47.47M	-36.78M	-26.75M
Discontinued Operations	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0
EPS (Diluted)+	-0.36	0.16	-0.35	-1.69	-1.16	-0.57
EPS Growth %	-	1.44%	-3.19%	-3.83%	0.31%	0.51%
EPS (Basic)	-0.05	0.03	-0.35	-1.69	-1.16	-0.57
Diluted Shares Outstanding	3.64M	3.98M	28.01M	28.08M	31.82M	46.75M
Basic Shares Outstanding	26.11M	21.11M	28.01M	28.08M	31.82M	46.75M
Dividend Payout Ratio	-	-	-	-	-	-

Balance Sheet

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	15.42M	16.41M	101.2M	61.14M	45.66M	42.78M
Cash & Short-Term Investments	9.68M	5.13M	87.52M	42.24M	28.48M	30.4M
Cash Only	4.14M	3.31M	87.52M	42.24M	28.48M	3.71M
Short-Term Investments	5.53M	1.81M	0	0	0	26.69M
Accounts Receivable	2.99M	6.57M	5.85M	4.28M	3.95M	4.31M
Days Sales Outstanding	54.24	76.61	57.92	37.74	39.28	41.7
Inventory	2.57M	3.58M	5.39M	12.25M	11.59M	6.8M
Days Inventory Outstanding	81.3	96.55	102.16	186.69	160.37	81.35
Other Current Assets	0	1.14M	0	0	1.63M	1.27M
Total Non-Current Assets+	43.09M	46.5M	65.31M	91.12M	82.93M	75.99M
Property, Plant & Equipment	5.45M	10.01M	29.81M	71.31M	66.84M	61.52M
Fixed Asset Turnover	3.69x	3.13x	1.24x	0.58x	0.55x	0.61x
Goodwill	16.61M	16.61M	16.61M	0	0	0
Intangible Assets	21M	19.85M	18.7M	17.56M	14.24M	13.09M
Long-Term Investments	0	0	0	0	0	0
Other Non-Current Assets	32K	24K	180K	2.25M	1.85M	1.38M
Total Assets+	58.51M	62.91M	166.51M	152.26M	128.59M	118.77M
Asset Turnover	0.34x	0.50x	0.22x	0.27x	0.29x	0.32x
Asset Growth %	-	0.08%	1.65%	-0.09%	-0.16%	-0.08%
Total Current Liabilities+	5.58M	3.96M	7.74M	10.88M	8.88M	11.21M
Accounts Payable	768K	1.64M	2.25M	2.45M	1.49M	825K
Days Payables Outstanding	24.33	44.07	42.58	37.33	20.65	9.87
Short-Term Debt	45K	0	0	0	0	4.04M
Deferred Revenue (Current)	0	0	200K	198K	16K	30K
Other Current Liabilities	0	845K	0	0	0	0
Current Ratio	2.76x	4.14x	13.07x	5.62x	5.14x	3.82x
Quick Ratio	2.30x	3.24x	12.37x	4.50x	3.84x	3.21x
Cash Conversion Cycle	111.21	129.09	117.5	187.1	179	113.18
Total Non-Current Liabilities+	40.02M	6.54M	15.56M	41.5M	29.68M	25.16M
Long-Term Debt	0	0	11.87M	21.98M	13.25M	9.44M
Capital Lease Obligations	0	0	0	18.11M	15.4M	14.88M
Deferred Tax Liabilities	3.9M	5.99M	3.15M	1.22M	919K	827K
Other Non-Current Liabilities	36.12M	554K	542K	191K	102K	10K
Total Liabilities	45.6M	10.51M	23.31M	52.38M	38.55M	36.38M
Total Debt+	45K	0	11.87M	42.31M	30.46M	30.17M
Net Debt	-4.1M	-3.31M	-75.65M	74K	1.97M	26.46M
Debt / Equity	0.00x	-	0.08x	0.42x	0.34x	0.37x
Debt / EBITDA	-	-	-	-	-	-
Net Debt / EBITDA	-	-0.49x	-	-	-	-
Interest Coverage	-	-	-20.39x	-	-42.69x	-38.06x
Total Equity+	12.91M	52.41M	143.2M	99.89M	90.04M	82.39M
Equity Growth %	-	3.06%	1.73%	-0.3%	-0.1%	-0.08%
Book Value per Share	3.55	13.18	5.11	3.56	2.83	1.76
Total Shareholders' Equity	12.91M	52.41M	143.2M	99.89M	90.04M	82.39M
Common Stock	0	0	0	0	0	1K
Retained Earnings	-1.3M	2.27M	-7.54M	-55.01M	-91.79M	-118.53M
Treasury Stock	0	0	0	0	0	0
Accumulated OCI	20K	7K	0	0	0	0
Minority Interest	0	0	0	0	0	0

Cash Flow

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	2.17M	2.5M	-9.07M	-27.4M	-18.81M	-12.39M
Operating CF Margin %	0.11%	0.08%	-0.25%	-0.66%	-0.51%	-0.33%
Operating CF Growth %	-	0.15%	-4.62%	-2.02%	0.31%	0.34%
Net Income	-1.3M	3.57M	-9.8M	-47.47M	-36.78M	-26.75M
Depreciation & Amortization	1.62M	2.04M	2.88M	3.17M	5.66M	6.58M
Stock-Based Compensation	0	300K	1.55M	3.71M	4.14M	3.67M
Deferred Taxes	-457K	2.09M	-2.84M	-1.93M	-304K	-92K
Other Non-Cash Items	12K	7K	906K	22.46M	6.22M	5.08M
Working Capital Changes	2.3M	-5.51M	-1.77M	-7.33M	2.25M	-873K
Change in Receivables	-104K	-2.35M	-49K	380K	314K	-494K
Change in Inventory	996K	-987K	-2.25M	-7.55M	330K	244K
Change in Payables	1.19M	-89K	270K	572K	-773K	-594K
Cash from Investing+	-8.16M	-1.74M	-17.52M	-28.15M	-7.74M	-27.27M
Capital Expenditures	-2.65M	-5.47M	-19.88M	-28.15M	-7.93M	-1.13M
CapEx % of Revenue	0.13%	0.17%	0.54%	0.68%	0.22%	0.03%
Acquisitions	-	-	-	-	-	-
Investments	-	-	-	-	-	-
Other Investing	61K	27K	529K	0	197K	125K
Cash from Financing+	8.57M	-1.6M	110.79M	10.27M	12.8M	14.89M
Debt Issued (Net)	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-
Other Financing	-6.75M	-1.55M	-3.77M	-307K	-32K	-214K
Net Change in Cash	-	-	-	-	-	-
Free Cash Flow+	-477K	-2.96M	-28.95M	-55.55M	-26.75M	-13.52M
FCF Margin %	-0.02%	-0.09%	-0.78%	-1.34%	-0.73%	-0.36%
FCF Growth %	-	-5.21%	-8.78%	-0.92%	0.52%	0.49%
FCF per Share	-0.13	-0.74	-1.03	-1.98	-0.84	-0.29
FCF Conversion (FCF/Net Income)	-1.66x	0.70x	0.93x	0.58x	0.51x	0.46x
Interest Paid	59K	36K	414K	0	0	1.55M
Taxes Paid	95K	323K	8K	0	0	39K

Key Ratios

Metric	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-10.11%	10.93%	-10.02%	-39.05%	-38.73%	-31.02%
Return on Invested Capital (ROIC)	-15.8%	12.08%	-15.44%	-44.47%	-27.79%	-19.52%
Gross Margin	42.67%	56.73%	47.76%	42.19%	28.07%	19.16%
Net Margin	-6.49%	11.41%	-26.57%	-114.6%	-100.26%	-70.86%
Debt / Equity	0.00x	-	0.08x	0.42x	0.34x	0.37x
Interest Coverage	-	-	-20.39x	-	-42.69x	-38.06x
FCF Conversion	-1.66x	0.70x	0.93x	0.58x	0.51x	0.46x
Revenue Growth	-	55.75%	17.88%	12.27%	-11.43%	2.89%

Revenue by Segment

	2021	2022	2023	2024
Lab Essentials	27.18M	31.77M	28.8M	28.88M
Lab Essentials Growth	-	16.88%	-9.35%	0.29%
Clinical Solutions	6.79M	8.45M	6.74M	7.1M
Clinical Solutions Growth	-	24.32%	-20.21%	5.33%
Other Product	1.39M	1.2M	1.15M	1.76M
Other Product Growth	-	-13.64%	-4.26%	54.01%
Sample Transport	1.53M	6K	-	-
Sample Transport Growth	-	-99.61%	-	-

Revenue by Geography

	2021	2022	2023	2024
UNITED STATES	-	40.1M	35M	35.92M
UNITED STATES Growth	-	-	-12.72%	2.63%
Non-US	-	1.32M	1.68M	1.83M
Non-US Growth	-	-	27.87%	8.43%
U S	35.81M	-	-	-
U S Growth	-	-	-	-
Non Us	1.08M	-	-	-
Non Us Growth	-	-	-	-

Frequently Asked Questions

Growth & Financials

Alpha Teknova, Inc. (TKNO) reported $39.8M in revenue for fiscal year 2024. This represents a 98% increase from $20.1M in 2019.

Alpha Teknova, Inc. (TKNO) grew revenue by 2.9% over the past year. Growth has been modest.

Alpha Teknova, Inc. (TKNO) reported a net loss of $18.2M for fiscal year 2024.

Dividend & Returns

Alpha Teknova, Inc. (TKNO) has a return on equity (ROE) of -31.0%. Negative ROE indicates the company is unprofitable.

Alpha Teknova, Inc. (TKNO) had negative free cash flow of $10.4M in fiscal year 2024, likely due to heavy capital investments.